Jeff Stier
Jeff Stier
Home  |  Bio  |  Mobile Site  |  Follow @Twitter
Pundicity: Informed Opinion and Review
 

Latest Articles

A Vision for Tobacco Policy; 2020 Edition

February 7, 2020  •  Real Clear Health

Smoking rates among adults and youth are plummeting. And while too many youth are vaping, legislators and regulators at the federal lave have recently made significant changes which are likely to improve the situation.

But state legislatures around the country are poised to do what some politicians do best: Overreact.

That's what happened in New Jersey this month, where Governor Murphy signed a bill banning the sale of flavored e-cigarettes to everyone, including adult smokers. Many states are also considering disproportionate taxes on e-cigarettes, a move that has already backfired in Minnesota, where quitters are become smokers again.

Continue to the full article  |  More articles

 

Feeling the Pain of High Drug Prices? We Prescribe Market Forces

January 30, 2020  •  Issues & Insights

Trump administration officials keep searching for solutions to rising prescription drug prices, which are increasing faster than inflation. "Drug makers and companies are not living up to their commitments on pricing. Not being fair to the consumer, or to our Country!" President Donald Trump tweeted last year.

Continue to the full article  |  More articles

 

Bravo to the Undoing of Michelle Obama's 'Signature Achievement'
The former first lady is allied with elitists who ignore and distort science to promote their leftist agendas. Fortunately, they're no longer in a position to ram their policies down our throats.

January 26, 2020  •  American Greatness

Following the Trump Administration's proposal of new rules for the Department of Agriculture's Food and Nutrition Service that would give schools more flexibility in the foods served in government-provided meals, the mainstream media lost no time in displaying their fawning Obama-worship. This was the lede in a January 17 Washington Post news story:

Continue to the full article  |  More articles

 

Yes, The FDA Is In Trouble, But The New York Times' Prescription Would Make It Worse
The FDA's failures are a result of too much regulatory dithering and bureaucracy. Yet the Times' prescriptions for change would just increase the dose.

January 20, 2020  •  The Federalist

A recent New York Times editorial about the Food and Drug Administration reflects a systematic weakness at the once-venerable Gray Lady: The members of the editorial board often rely on sloganeering and popular wisdom instead of substantive evidence.

The editorial was headlined, "The FDA Is in Trouble. Here's How to Fix It." The agency is in trouble. But it's due to the very kinds of "fixes" the Times recommends.

The FDA is highly bureaucratic and risk averse, leading to a slow and expensive drug approval process—at last count, more than $2.5 billion to bring a new drug to market. Yet the armchair quarterbacks at the Times want to slow it down even more and increase the cost and risks of innovating.

Continue to the full article  |  More articles

 

The Deep State Will Challenge the New FDA Head
FDA Commissioner Dr. Stephen Hahn will need to disrupt the agency's tendency to delay and over-regulate

December 19, 2019  •  American Greatness

Now that the Trump Administration's new FDA commissioner, Dr. Stephen Hahn, has been confirmed, he'll find he has one of the most difficult and important jobs in government. The FDA's purview is wide, regulating pharmaceutical and other medical, food, and vaping products that account for more than 25 cents of every consumer dollar, over a trillion dollars annually.

Continue to the full article  |  More articles

home   |   biography   |   articles   |   blog   |   media coverage   |   spoken   |   audio/video   |   announcements   |   mailing list   |   mobile site